Price $4.88 |
Market Cap
226.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.17
|
P/S
-
|
Dividend %
-
|
|
P/CF
17.6
|
P/FCF
-
|
Op. Cash Flow
-48.9K
|
FCF
-2.0
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-89.20%
|
ROI
-58.30%
|
|
ROA
-62.30%
|
EPS Growth
-114.20%
|
Current Ratio
6.4
|
Debt/Equity
13.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $4.95 | - | - | 1.47B | Strong Buy |
| IRIDEX Corporation (IRIX) | $6.50 | - | - | 83.4M | Strong Buy |
| Boston Scientific Corporation (BSX) | $39.54 | - | - | 56.22B | Strong Buy |
| Verastem Inc (VSTM) | $2.22 | - | - | 400.7M | Strong Buy |
| RCMW Group Inc (HPTYD) | $2.03 | - | - | 14.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
